Liberia: 200 Volunteers Complete Ebola Trial Test

Out of 1,500 volunteers that participated in the US-joint Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) clinical trial test, 200 were on Monday certificated after a one year observation revealed that they did not develop any symptoms from the vaccine.

During a program held on Monday, January 18 at the Redemption Hospital, which brought together local and international staff of PREVAIL, Mr. Anthony S. Fauci, M.D., Director of the US National Institute of Allergy and Infectious Diseases (NIAID), expressed gratitude to health workers, including staff of PREVAIL, for the level of progress in the study.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.